87 related articles for article (PubMed ID: 16149540)
1. [3-methoxy-4-hydroxyphenylglycol (MHPG)].
Yoneda M; Sanada H
Nihon Rinsho; 2005 Aug; 63 Suppl 8():404-6. PubMed ID: 16149540
[No Abstract] [Full Text] [Related]
2. [Clinical significance of 3-methoxy-4-hydroxyphenylethylene glycol analysis in endocrine tests of the medulla and sympathetic nervous system].
Shigetomi S
Nihon Rinsho; 1989 Dec; 48 Suppl():1168-70. PubMed ID: 2621839
[No Abstract] [Full Text] [Related]
3. [3-Methoxy-4 -hydroxyphenylglycol (MHPG)].
Yoneda M; Sanada H
Nihon Rinsho; 2010 Jul; 68 Suppl 7():426-8. PubMed ID: 20960809
[No Abstract] [Full Text] [Related]
4. [3,4-Dihydroxyphenylacetic acid (DOPAC)].
Sasaki M; Sanada H
Nihon Rinsho; 2005 Aug; 63 Suppl 8():384-7. PubMed ID: 16149535
[No Abstract] [Full Text] [Related]
5. [Assessment of mental condition by saliva level of 3-methoxy-4-hydroxyphenylglycol].
Yamada S
Seishin Shinkeigaku Zasshi; 2005; 107(7):712-7. PubMed ID: 16146187
[TBL] [Abstract][Full Text] [Related]
6. [Saliva level of free-3-methoxy-4-hydroxyphenylglycol in patients with anxiety disorders].
Yamada S; Yajima J; Tsuda A; Yamauchi K; Maeda H; Tanaka M
Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Apr; 19(2):67-71. PubMed ID: 10464777
[TBL] [Abstract][Full Text] [Related]
7. [Beta-endorphin (beta-end)].
Kato Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():213-5. PubMed ID: 16149493
[No Abstract] [Full Text] [Related]
8. Rapid HPLC assay with coulometric detection for norepinephrine and 3-methoxy-4-hydroxyphenylglycol in the mouse brain.
Murai S; Saito H; Masuda Y; Ohkubo N; Itoh T
J Pharmacol Toxicol Methods; 1994 Oct; 32(2):99-103. PubMed ID: 7532470
[TBL] [Abstract][Full Text] [Related]
9. Saliva level of free 3-methoxy-4-hydroxyphenylglycol (MHPG) as a biological index of anxiety disorders.
Yamada S; Yamauchi K; Yajima J; Hisadomi S; Maeda H; Toyomasu K; Tanaka M
Psychiatry Res; 2000 Apr; 93(3):217-23. PubMed ID: 10760380
[TBL] [Abstract][Full Text] [Related]
10. Neurochemical abnormalities in anorexia nervosa: similarities to affective disorders.
Gwirtsman HE; Gerner RH
Biol Psychiatry; 1981 Oct; 16(10):991-5. PubMed ID: 7306620
[TBL] [Abstract][Full Text] [Related]
11. Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini review.
Yoshimura R; Nakamura J; Shinkai K; Ueda N
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):611-6. PubMed ID: 15276685
[TBL] [Abstract][Full Text] [Related]
12. Plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) and clinical symptoms in Alzheimer's disease.
Lawlor BA; Bierer LM; Ryan TM; Schmeidler J; Knott PJ; Williams LL; Mohs RC; Davis KL
Biol Psychiatry; 1995 Aug; 38(3):185-8. PubMed ID: 7578662
[TBL] [Abstract][Full Text] [Related]
13. [5-Hydroxyindole acetic acid (5HIAA)].
Saijoh K; Katsuyama H
Nihon Rinsho; 2005 Aug; 63 Suppl 8():417-20. PubMed ID: 16149543
[No Abstract] [Full Text] [Related]
14. Gas-liquid chromatographic method for routine detection of plasma sulfo-, gluco-, and free 3-methoxy-4-hydroxyphenylglycol.
Piletz JE; Halaris A
Clin Chim Acta; 1989 Nov; 185(2):165-76. PubMed ID: 2624996
[TBL] [Abstract][Full Text] [Related]
15. Urinary 3-methoxy-4-hydroxyphenylglycol (MHPG) excretion in depression.
Steiner M; Radwan M; Elizur A; Blum I; Atsmon A; Davidson S
Jpn J Exp Med; 1979 Apr; 49(2):95-9. PubMed ID: 480680
[TBL] [Abstract][Full Text] [Related]
16. Determination of the primary metabolite of central nervous system norepinephrine, 3-methoxy-4-hydroxy-phenethyleneglycol, in mouse brain and brain perfusate by high-performance liquid chromatography with electrochemical detection.
Towell JF; Erwin VG
J Chromatogr; 1981 May; 223(2):295-303. PubMed ID: 7251783
[TBL] [Abstract][Full Text] [Related]
17. Relationship between saliva level of 3-methoxy-4-hydroxyphenylglycol and mental health in the elderly general population.
Li GY; Watanabe I; Kunitake Y; Sugataka K; Muraoka T; Kojima N; Kawashima T; Yamada S
Psychiatry Clin Neurosci; 2008 Oct; 62(5):562-7. PubMed ID: 18950376
[TBL] [Abstract][Full Text] [Related]
18. 3-Methoxy-4-hydroxyphenylglycol and primary depression: clinical and pharmacological considerations.
Sacchetti E; Allaria E; Negri F; Biondi PA; Smeraldi E; Cazzullo CL
Biol Psychiatry; 1979 Jun; 14(3):473-84. PubMed ID: 476232
[TBL] [Abstract][Full Text] [Related]
19. Catecholamine measures for diagnosis and treatment of patients with depressive disorders.
Schatzberg AF; Orsulak PJ; Rosenbaum AH; Kruger ER; Schildkraut JJ; Cole JO
J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):35-9. PubMed ID: 7440524
[TBL] [Abstract][Full Text] [Related]
20. [Antidepressants].
Yasuda K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():372-6. PubMed ID: 15658341
[No Abstract] [Full Text] [Related]
[Next] [New Search]
